FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: ValueSet/2.16.840.1.113883.3.1444.3.163

Packageus.nlm.vsac
Resource TypeValueSet
Id2.16.840.1.113883.3.1444.3.163
FHIR VersionR4
Sourcehttp://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.3.1444.3.163/expansion
URLhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.163
Version20210521
Statusactive
Date2021-05-21T01:00:57-04:00
NameEnfortumabInjectable
TitleEnfortumab Injectable
Realmus
Authorityhl7
Purpose(Clinical Focus: The purpose of this value set is to represent concepts of medication Enfortumab.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a medication Enfortumab; generic; prescribable; injectable.),(Exclusion Criteria: Excludes concepts that represent non-prescribable branded drugs, components or ingredients.)

Resources that use this resource

ValueSet
2.16.840.1.113883.3.1444.5.228Low Emetic Risk Intravenous Antineoplastic Agent

Resources that this resource uses

CodeSystem
rxnormRxNorm

Narrative

No narrative content found in resource


Source

{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113883.3.1444.3.163",
  "meta": {
    "versionId": "6",
    "lastUpdated": "2023-12-21T17:43:03.000-05:00",
    "profile": [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail": {
        "name": "American Society of Clinical Oncology Author"
      }
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate": "2025-04-08"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate": "2021-05-21"
    }
  ],
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.163",
  "identifier": [
    {
      "system": "urn:ietf:rfc:3986",
      "value": "urn:oid:2.16.840.1.113883.3.1444.3.163"
    }
  ],
  "version": "20210521",
  "name": "EnfortumabInjectable",
  "title": "Enfortumab Injectable",
  "status": "active",
  "experimental": false,
  "date": "2021-05-21T01:00:57-04:00",
  "publisher": "American Society of Clinical Oncology Steward",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "urn:iso:std:iso:3166",
          "code": "US"
        }
      ]
    }
  ],
  "purpose": "(Clinical Focus: The purpose of this value set is to represent concepts of medication Enfortumab.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a medication Enfortumab; generic; prescribable; injectable.),(Exclusion Criteria: Excludes concepts that represent non-prescribable branded drugs, components or ingredients.)",
  "compose": {
    "include": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "concept": [
          {
            "code": "2268311",
            "display": "enfortumab vedotin-ejfv 20 MG Injection"
          },
          {
            "code": "2268317",
            "display": "enfortumab vedotin-ejfv 30 MG Injection"
          }
        ]
      }
    ]
  },
  "expansion": {
    "identifier": "urn:uuid:89e716d5-77d3-4269-a54f-290d4d5a0fd4",
    "timestamp": "2025-05-23T21:53:40-04:00",
    "total": 2,
    "contains": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "2268311",
        "display": "enfortumab vedotin-ejfv 20 MG Injection"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "2268317",
        "display": "enfortumab vedotin-ejfv 30 MG Injection"
      }
    ]
  }
}